187 related articles for article (PubMed ID: 29801513)
1. Absolute oral bioavailability and disposition kinetics of puerarin in female rats.
Anukunwithaya T; Poo P; Hunsakunachai N; Rodsiri R; Malaivijitnond S; Khemawoot P
BMC Pharmacol Toxicol; 2018 May; 19(1):25. PubMed ID: 29801513
[TBL] [Abstract][Full Text] [Related]
2. Comparative Pharmacokinetics of Puerarin Alone and in Pueraria mirifica Extract in Female Cynomolgus Monkeys.
Namken S; Songvut P; Nuengchamnong N; Kemthong T; Khemawoot P; Malaivijitnond S
Planta Med; 2021 Apr; 87(5):395-403. PubMed ID: 33063303
[No Abstract] [Full Text] [Related]
3. Pharmacokinetic, tissue distribution, and excretion of puerarin and puerarin-phospholipid complex in rats.
Li Y; Pan WS; Chen SL; Xu HX; Yang DJ; Chan AS
Drug Dev Ind Pharm; 2006 Apr; 32(4):413-22. PubMed ID: 16638679
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution of puerarin and its conjugated metabolites in rats assessed by liquid chromatography-tandem mass spectrometry.
Prasain JK; Peng N; Moore R; Arabshahi A; Barnes S; Wyss JM
Phytomedicine; 2009 Jan; 16(1):65-71. PubMed ID: 19027277
[TBL] [Abstract][Full Text] [Related]
6. Tracking deposition of a 14C-radiolabeled kudzu hairy root-derived isoflavone-rich fraction into bone.
Mun JG; Grannan MD; Lachcik PJ; Rogers RB; Yousef GG; Grace MH; Janle EM; Wu QL; Simon JE; Weaver CM; Lila MA
Exp Biol Med (Maywood); 2010 Oct; 235(10):1224-35. PubMed ID: 20851832
[TBL] [Abstract][Full Text] [Related]
7. Metabolites of puerarin identified by liquid chromatography tandem mass spectrometry: similar metabolic profiles in liver and intestine of rats.
Luo CF; Yuan M; Chen MS; Liu SM; Ji H
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):363-70. PubMed ID: 20006564
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oral bioavailability of genistein and genistin in rats.
Kwon SH; Kang MJ; Huh JS; Ha KW; Lee JR; Lee SK; Lee BS; Han IH; Lee MS; Lee MW; Lee J; Choi YW
Int J Pharm; 2007 Jun; 337(1-2):148-54. PubMed ID: 17280808
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
[TBL] [Abstract][Full Text] [Related]
10. Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry.
Prasain JK; Jones K; Brissie N; Moore R; Wyss JM; Barnes S
J Agric Food Chem; 2004 Jun; 52(12):3708-12. PubMed ID: 15186086
[TBL] [Abstract][Full Text] [Related]
11. Anti-osteoporotic effects of Pueraria candollei var. mirifica on bone mineral density and histomorphometry in estrogen-deficient rats.
Suthon S; Jaroenporn S; Charoenphandhu N; Suntornsaratoon P; Malaivijitnond S
J Nat Med; 2016 Apr; 70(2):225-33. PubMed ID: 26815435
[TBL] [Abstract][Full Text] [Related]
12. Urinary and biliary metabolites of puerarin in rats.
Yasuda T; Kano Y; Saito K; Ohsawa K
Biol Pharm Bull; 1995 Feb; 18(2):300-3. PubMed ID: 7742802
[TBL] [Abstract][Full Text] [Related]
13. Effects of glycyrrhizin on the pharmacokinetics of puerarin in rats.
Zhao Q; Wang Y; Wang H; Feng L
Xenobiotica; 2018 Nov; 48(11):1157-1163. PubMed ID: 29099639
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica.
Tiyasatkulkovit W; Charoenphandhu N; Wongdee K; Thongbunchoo J; Krishnamra N; Malaivijitnond S
Phytomedicine; 2012 Oct; 19(13):1147-55. PubMed ID: 22951392
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Pharmacokinetics of Puerarin via Different Drug Administration Routes Based on Middle Cerebral Artery Occlusion Model.
Li P; Bai J; Dong B; Lu Y; Zhang S; Guo S; Tan N; Zhao M; Du S; Cao P
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):719-727. PubMed ID: 27928655
[TBL] [Abstract][Full Text] [Related]
16. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
Ge B; Zhang Z; Lam TT; Zuo Z
Biopharm Drug Dispos; 2017 Jan; 38(1):33-49. PubMed ID: 27925234
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of puerarin and hydrochlorothiazide from maijunan tablets in rats].
Zhang X; Han FM; Du P; Chen Y
Yao Xue Xue Bao; 2009 Sep; 44(9):1056-60. PubMed ID: 20055185
[TBL] [Abstract][Full Text] [Related]
18. [Effect of verapamil on pharmacokinetics of puerarin in rats].
Cui SM; Ma YB
Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):2033-6. PubMed ID: 19086648
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Tissue Distribution Kinetics of Puerarin in Rats Using Indirect Competitive ELISA.
Kong H; Wang X; Shi R; Zhao Y; Cheng J; Yan X; Liu X; Wang Y; Zhang M; Wang Q; Qu H
Molecules; 2017 Jun; 22(6):. PubMed ID: 28587251
[TBL] [Abstract][Full Text] [Related]
20. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations.
Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX
Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
